A Comparison of Static and Dynamic PET/CT (HYPOTHESIS Generation Study)
NCT ID: NCT05110443
Last Updated: 2025-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
500 participants
INTERVENTIONAL
2020-02-18
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1\. To obtain and compare parametric as well as traditional static PET/CT images and determine the number of lesions identified on each type of scan.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949
Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation
NCT00835783
PET Response During Chemoradiation of Lung Cancer
NCT02315053
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Most scans will be performed with FDG, with indications for PET/CT including hematological, urogenital, thoracic and gynecological malignancies as well as patients with suspected infections and inflammation. We will also include patients referred for PET/CT using other radiotracers, such as tumour markers (68Ga-DOTATOC, 18F-FDOPA, 68Ga-PSMA, 18F-PSMA).
Instead of the usual procedure of having the injection of the radiotracer in the waiting room and having to wait 60 minutes before being moved to the scanner room for imaging, the study participants will be injected with the radiotracer already laying on the scanner bed and the scan will commence immediately.
Therefore, in this study the patients are still only being scanned once, but we are gathering PET information in a different way.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Main arm
Patients will perform a D-WB PET/CT scan as a substitute for their clinical PET.
D-WB PET/CT
Instead of the usual procedure of having the injection of the radiotracer in the waiting room and having to wait 60 minutes before being moved to the scanner room for imaging, the study participants will be injected with the radiotracer already laying on the scanner bed and the scan will commence immediately.
Therefore, in this study the patients are still only being scanned once, but we are gathering PET information in a different way.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
D-WB PET/CT
Instead of the usual procedure of having the injection of the radiotracer in the waiting room and having to wait 60 minutes before being moved to the scanner room for imaging, the study participants will be injected with the radiotracer already laying on the scanner bed and the scan will commence immediately.
Therefore, in this study the patients are still only being scanned once, but we are gathering PET information in a different way.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good performance status, which permits patients to lay still in the scanner for ca. 70 min.
Exclusion Criteria
* Patients that can not tolerate a PET scan (f.ex: claustrophobia).
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
André H. Dias
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pedersen MA, Dias AH, Hjorthaug K, Gormsen LC, Fledelius J, Johnsson AL, Borgquist S, Tramm T, Munk OL, Vendelbo MH. Increased lesion detectability in patients with locally advanced breast cancer-A pilot study using dynamic whole-body [18F]FDG PET/CT. EJNMMI Res. 2024 Mar 25;14(1):31. doi: 10.1186/s13550-024-01096-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYPOTHESIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.